Clinical Trial

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-02
notable Primary completion pushed: 2031-04-01 -> 2031-09-01 2026-06-02
minor Completion pushed: 2031-04-01 -> 2031-09-01 2026-06-02
Trial Details
NCT Number NCT07392580
Lead Sponsor University of Miami
Conditions Laryngeal Squamous Cell Carcinoma
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2031-09-01 (estimated)
Study Completion 2031-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-01